184 related articles for article (PubMed ID: 28546739)
1. Erratum: Switching to preservative-free latanoprost: impact on tolerability and patient satisfaction [Corrigendum].
Clin Ophthalmol; 2017; 11():887. PubMed ID: 28546739
[TBL] [Abstract][Full Text] [Related]
2. Switching to preservative-free latanoprost: impact on tolerability and patient satisfaction.
Muñoz Negrete FJ; Lemij HG; Erb C
Clin Ophthalmol; 2017; 11():557-566. PubMed ID: 28356710
[TBL] [Abstract][Full Text] [Related]
3. Corrigendum.
Paediatr Child Health; 2015; 20(8):466-7. PubMed ID: 26744561
[TBL] [Abstract][Full Text] [Related]
4. Switching to preservative-free latanoprost: impact on tolerability and patient satisfaction.
Beck DER; El-Assal K; McGarry K; Wride NK
Clin Ophthalmol; 2017; 11():1565-1566. PubMed ID: 28894354
[No Abstract] [Full Text] [Related]
5. Switching from a preserved to a preservative-free prostaglandin preparation in topical glaucoma medication.
Uusitalo H; Chen E; Pfeiffer N; Brignole-Baudouin F; Kaarniranta K; Leino M; Puska P; Palmgren E; Hamacher T; Hofmann G; Petzold G; Richter U; Riedel T; Winter M; Ropo A
Acta Ophthalmol; 2010 May; 88(3):329-36. PubMed ID: 20546237
[TBL] [Abstract][Full Text] [Related]
6. Benefits of switching from latanoprost to preservative-free tafluprost eye drops: a meta-analysis of two Phase IIIb clinical trials.
Uusitalo H; Egorov E; Kaarniranta K; Astakhov Y; Ropo A
Clin Ophthalmol; 2016; 10():445-54. PubMed ID: 27041987
[TBL] [Abstract][Full Text] [Related]
7. Changes in Ocular Surface Characteristics after Switching from Benzalkonium Chloride-Preserved Latanoprost to Preservative-Free Tafluprost or Benzalkonium Chloride-Preserved Tafluprost.
Tokuda N; Kitaoka Y; Matsuzawa A; Tsukamoto A; Sase K; Sakae S; Takagi H
J Ophthalmol; 2017; 2017():3540749. PubMed ID: 28831305
[TBL] [Abstract][Full Text] [Related]
8. The RELIEF study: Tolerability and efficacy of preservative-free latanoprost in the treatment of glaucoma or ocular hypertension.
Misiuk-Hojlo M; Pomorska M; Mulak M; Rekas M; Wierzbowska J; Prost M; Wasyluk J; Lubinski W; Podboraczynska-Jodko K; Romaniuk W; Kinasz R; Ortyl-Markiewicz R; Mocko L; Zaleska-Zmijewska A; Rokicki D; Baudouin C
Eur J Ophthalmol; 2019 Mar; 29(2):210-215. PubMed ID: 29998767
[TBL] [Abstract][Full Text] [Related]
9. Erratum: Patient satisfaction with cardiac rehabilitation: association with utilization, functional capacity, and heart-health behaviors [Corrigendum].
Patient Prefer Adherence; 2017; 11():1541. PubMed ID: 28979102
[TBL] [Abstract][Full Text] [Related]
10. Erratum: Ocular pharmacokinetics and tolerability of bimatoprost ophthalmic solutions administered once or twice daily in rabbits, and clinical dosing implications [Corrigendum].
Clin Ophthalmol; 2018; 12():1471. PubMed ID: 30154643
[TBL] [Abstract][Full Text] [Related]
11. Erratum: Impact of conjunctival autograft on pterygium treatment: evaluation of related symptoms and patients' satisfaction after surgery [Corrigendum].
Clin Ophthalmol; 2018; 12():1267. PubMed ID: 30050278
[TBL] [Abstract][Full Text] [Related]
12. Erratum: Effects of switching from olanzapine to aripiprazole on the metabolic profiles of patients with schizophrenia and metabolic syndrome: a double-blind, randomized, open-label study [Corrigendum].
Neuropsychiatr Dis Treat; 2015; 11():863. PubMed ID: 25848284
[TBL] [Abstract][Full Text] [Related]
13. Erratum: Prolongation of injection interval after switching therapy from ranibizumab to aflibercept in Japanese patients with macular edema secondary to branch retinal vein occlusion [Corrigendum].
Clin Ophthalmol; 2017; 11():619. PubMed ID: 28435211
[TBL] [Abstract][Full Text] [Related]
14. Erratum: Burnout and work satisfaction in general practitioners practicing in rural areas: results from the HaMEdSi study [Corrigendum].
Psychol Res Behav Manag; 2018; 11():543-544. PubMed ID: 30992684
[TBL] [Abstract][Full Text] [Related]
15. 24-Hour Efficacy and Ocular Surface Health with Preservative-Free Tafluprost Alone and in Conjunction with Preservative-Free Dorzolamide/Timolol Fixed Combination in Open-Angle Glaucoma Patients Insufficiently Controlled with Preserved Latanoprost Monotherapy.
Konstas AG; Boboridis KG; Kapis P; Marinopoulos K; Voudouragkaki IC; Panayiotou D; Mikropoulos DG; Pagkalidou E; Haidich AB; Katsanos A; Quaranta L
Adv Ther; 2017 Jan; 34(1):221-235. PubMed ID: 27913991
[TBL] [Abstract][Full Text] [Related]
16. Erratum: A single-arm, investigator-initiated study of the efficacy, safety, and tolerability of intravitreal aflibercept injection in subjects with exudative age-related macular degeneration previously treated with ranibizumab or bevacizumab (ASSESS study): 12-month analysis [Corrigendum].
Clin Ophthalmol; 2017; 11():303. PubMed ID: 28223773
[TBL] [Abstract][Full Text] [Related]
17. Switch from BAK-preserved to preservative-free latanoprost decreases anterior chamber flare in POAG patients.
Kestelyn PA; Kestelyn PG; De Bacquer D; Stevens AM
Int Ophthalmol; 2019 Jan; 39(1):105-109. PubMed ID: 29274019
[TBL] [Abstract][Full Text] [Related]
18. Corrigendum.
Sun XH; Yu HZ; Yang MM; Yang YM; Dang ZM
J Cachexia Sarcopenia Muscle; 2015 Jun; 6(2):192. PubMed ID: 26140254
[TBL] [Abstract][Full Text] [Related]
19. Erratum: Hepatitis C infection in Egypt: prevalence, impact and management strategies [Corrigendum].
Hepat Med; 2017; 9():35. PubMed ID: 28794662
[TBL] [Abstract][Full Text] [Related]
20. Erratum: corrigendum.
Clin Ophthalmol; 2011; 5():1557. PubMed ID: 22125401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
